These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10547540)

  • 21. Intralesional ethanol in the treatment of unresectable liver cancer.
    Livraghi T; Lazzaroni S; Meloni F; Torzilli G; Vettori C
    World J Surg; 1995; 19(6):801-6. PubMed ID: 8553669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study.
    Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H
    Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients.
    Livraghi T
    Ital J Gastroenterol; 1992 Feb; 24(2):72-4. PubMed ID: 1315592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Okusaka T; Yoshimori M; Nakasuka H; Shimada K; Yamasaki S; Nakanishi Y; Sakamoto M
    Cancer; 1998 May; 82(9):1638-42. PubMed ID: 9576282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
    Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
    Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Schoppmeyer K; Weis S; Mössner J; Fleig WE
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea.
    Sung YM; Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Paik SW; Yoo BC; Koh KC; Lee JH; Choi MS
    Korean J Radiol; 2006; 7(3):187-92. PubMed ID: 16969048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
    Tsai WL; Cheng JS; Lai KH; Lin CP; Lo GH; Hsu PI; Yu HC; Lin CK; Chan HH; Chen WC; Chen TA; Li WL; Liang HL
    Aliment Pharmacol Ther; 2008 Aug; 28(3):304-11. PubMed ID: 19086330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
    Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
    Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.
    Fukuda S; Itamoto T; Amano H; Kohashi T; Ohdan H; Tashiro H; Asahara T
    World J Surg; 2007 Feb; 31(2):345-52. PubMed ID: 17219274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching.
    Cho YB; Lee KU; Suh KS; Kim YJ; Yoon JH; Lee HS; Hahn S; Park BJ
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1643-9. PubMed ID: 17845692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.
    Livraghi T; Giorgio A; Marin G; Salmi A; de Sio I; Bolondi L; Pompili M; Brunello F; Lazzaroni S; Torzilli G
    Radiology; 1995 Oct; 197(1):101-8. PubMed ID: 7568806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma--study on its therapeutic effect and prognosis based on long-term observation].
    Kita K; Ebara M; Sugiura N; Ohto M
    Nihon Shokakibyo Gakkai Zasshi; 1994 Oct; 91(10):1946-55. PubMed ID: 7967130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local injection therapy for hepatocellular carcinoma.
    Lin XD; Lin LW
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):16-21. PubMed ID: 16481276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection.
    Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y
    Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.